Clinical Trial Management Systems Market

Clinical Trial Management System Market (Mode of Delivery - On-premise, Web-based, Cloud-based; Component- Software, Hardware, Services; Type - Enterprise-based, Site-based; End use - Pharmaceutical Industries, Contract Research Organizations, Health Care Providers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL544
  • Published On : Apr 2018
  • No. of Pages : 241
  • Category : IT & Telecom

1. Preface
     1.1.Report Scope and Market Segmentation
     1.2.Research Highlights
     1.3.Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary : Global Clinical Trial Management System Market

4. Market Overview
     4.1. Introduction
            4.1.1. Clinical Trial Management System Definition
            4.1.2. Key Industry Evolutions/ Developments
     4.2. Overview: Global Clinical Trial Management System (CTSM) Market
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunities
     4.5. Porter’s Five Force Analysis
     4.6. Product Pipeline
     4.7. Standards for data management in clinical trial study

5. Global Clinical Trial Management System (CTMS) Market Analysis, by Mode of Delivery
     5.1. Introduction & Definition
     5.2. Key Findings 
     5.3. Market Value Forecast, by Mode of Delivery , 2015–2025
            5.3.1. On-premise
            5.3.2. Web-based
            5.3.3. Cloud-based
     5.4. Market Attractiveness, by Mode of Delivery

6. Global Clinical Trial Management System (CTMS) Market Analysis, by Component
     6.1. Introduction & Definition
     6.2. Key Findings 
     6.3. Market Value Forecast, by Component, 2015–2025
            6.3.1. Software
            6.3.2. Hardware
            6.3.3. Services
     6.4. Market Attractiveness, by Components

7. Global Clinical Trial Management System (CTMS) Market Analysis, by Type
     7.1. Introduction & Definition
     7.2. Key Findings 
     7.3. Market Value Forecast, by Type, 2015–2025
            7.3.1. Enterprise-based
            7.3.2. Site-based
     7.4. Market Attractiveness, by Type

8. Global Clinical Trial Management System (CTMS) Market Analysis, by End-user
     8.1. Introduction & Definition
     8.2. Key Findings 
     8.3. Market Value Forecast, by End-user, 2015–2025
            8.3.1. Pharmaceutical Industries
            8.3.2. Contract Research Organizations
            8.3.3. Healthcare Providers
     8.4. Market Attractiveness, by End-user

9. Global Clinical Trial Management System (CTMS) Market Analysis, by Region
     9.1. Key Findings
     9.2. Market Value Forecast, by Region
            9.2.1. North America
            9.2.2. Europe
            9.2.3. Asia
            9.2.4. Rest of the World 
     9.3. Market Attractiveness by Region

10. North America Clinical Trial Management System Analysis and Forecast
     10.1. Key Findings
     10.2. North America Clinical Trial Management System (CTMS) Market Overview
     10.3. Market Value Share, by Country/Sub-regions
            10.3.1. U.S. 
            10.3.2. Canada
     10.4. Market Value Share, by Mode of Delivery
            10.4.1. Cloud-bases
            10.4.2. Web-based
            10.4.3. On-premise
     10.5. Market Value Share, by Component
            10.5.1. Software
            10.5.2. Hardware
            10.5.3. Services
     10.6. Market Value Share, by Type
            10.6.1. Enterprise-based
            10.6.2. Site-based
     10.7. Market Value Share, by End-user
            10.7.1. Pharmaceutical Industries
            10.7.2. Contract Research Organizations
            10.7.3. Healthcare Providers 
     10.8. Market Attractiveness Analysis
            10.8.1. By Country/Sub-region
            10.8.2. By Mode of Delivery
            10.8.3. By Component
            10.8.4. By Type
            10.8.5. By End-user

11. Europe Clinical Trial Management System Analysis and Forecast
     11.1. Key Findings
     11.2. Europe Clinical Trial Management System (CTMS) Market Overview
     11.3. Market Value Share, by Country/Sub-regions
            11.3.1. U.K. 
            11.3.2. France
            11.3.3. Germany
            11.3.4. Russia
            11.3.5. Poland
            11.3.6. Rest of Europe
     11.4. Market Value Share, by Mode of Delivery
            11.4.1. Cloud-based
            11.4.2. Web-based
            11.4.3. On-premise
     11.5. Market Value Share, by Component
            11.5.1. Software
            11.5.2. Hardware
            11.5.3. Services
     11.6. Market Value Share, by Type
            11.6.1. Enterprise-based
            11.6.2. Site-based
     11.7. Market Value Share, by End-user
            11.7.1. Pharmaceutical Industries
            11.7.2. Contract Research Organizations
            11.7.3. Healthcare Providers 
     11.8. Market Attractiveness Analysis
            11.8.1. By Country/Sub-region
            11.8.2. By Mode of Delivery
            11.8.3. By Component
            11.8.4. By Type
            11.8.5. By End-user

12. Asia Clinical Trial Management System Analysis and Forecast
     12.1. Key Findings
     12.2. Asia Clinical Trial Management System (CTMS) Market Overview
     12.3. Market Value Share, by Country/Sub-regions
            12.3.1. China 
            12.3.2. South Korea
            12.3.3. Taiwan
            12.3.4. India
            12.3.5. Rest of Asia
     12.4. Market Value Share, by Mode of Delivery
            12.4.1. Cloud-based
            12.4.2. Web-based
            12.4.3. On-premise
     12.5. Market Value Share, by Component
            12.5.1. Software
            12.5.2. Hardware
            12.5.3. Services
     12.6. Market Value Share By Type
            12.6.1. Enterprise-based
            12.6.2. Site-based
     12.7. Market Value Share By End-user
            12.7.1. Pharmaceutical Industries
            12.7.2. Contract Research Organizations
            12.7.3. Healthcare Providers 
     12.8. Market Attractiveness Analysis
            12.8.1. By Country/Sub-region
            12.8.2. By Mode of Delivery
            12.8.3. By Component
            12.8.4. By Type
            12.8.5. By End-user

13. Rest of World (ROW) Clinical Trial Management System Market Analysis and Forecast
     13.1. Key Findings
     13.2. ROW Clinical Trial Management System (CTMS) Market Overview
     13.3. Market Value Share By Mode of Delivery
            13.3.1. Cloud-based
            13.3.2. Web-based
            13.3.3. On-premise
     13.4. Market Value Share By Component
            13.4.1. Software
            13.4.2. Hardware
            13.4.3. Services
     13.5. Market Value Share By Type
            13.5.1. Enterprise-based
            13.5.2. Site-based
     13.6. Market Value Share By End-user
            13.6.1. Pharmaceutical Industries
            13.6.2. Contract Research Organizations
            13.6.3. Healthcare Providers 
     13.7. Market Attractiveness Analysis
            13.7.1. By Mode of Delivery
            13.7.2. By Component
            13.7.3. By Type
            13.7.4. By End-user

14. Competition Landscape
     14.1.Market Player – Competition Matrix (By Tier and Size of companies)
     14.2.Market Share Analysis By Company (2016)
     14.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.3.1. Oracle
                     14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.1.2. Financial Overview
                     14.3.1.3. Product Portfolio
                     14.3.1.4. SWOT Analysis 
                     14.3.1.5. Strategic Overview
            14.3.2. Medidata
                     14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.2.2. Financial Overview
                     14.3.2.3. Product Portfolio
                     14.3.2.4. SWOT Analysis 
                     14.3.2.5. Strategic Overview
            14.3.3. PAREXEL International Corporation
                     14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.3.2. Financial Overview
                     14.3.3.3. Product Portfolio
                     14.3.3.4. SWOT Analysis 
                     14.3.3.5. Strategic Overview
            14.3.4. International Business Machines Corporation 
                     14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.4.2. Financial Overview
                     14.3.4.3. Product Portfolio
                     14.3.4.4. SWOT Analysis 
                     14.3.4.5. Strategic Overview
            14.3.5. Cinven
                     14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.5.2. Financial Overview
                     14.3.5.3. Product Portfolio
                     14.3.5.4. SWOT Analysis 
                     14.3.5.5. Strategic Overview
            14.3.6. MedNet Solutions, Inc
                     14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.6.2. Financial Overview
                     14.3.6.3. Product Portfolio
                     14.3.6.4. SWOT Analysis 
                     14.3.6.5. Strategic Overview
            14.3.7. Microsoft
                     14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.7.2. Financial Overview
                     14.3.7.3. Product Portfolio
                     14.3.7.4. SWOT Analysis 
                     14.3.7.5. Strategic Overview
            14.3.8. Apple Inc
                     14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.8.2. Financial Overview
                     14.3.8.3. Product Portfolio
                     14.3.8.4. SWOT Analysis 
                     14.3.8.5. Strategic Overview
            14.3.9. Bio-Optronics, Inc.
                     14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.9.2. Financial Overview
                     14.3.9.3. Product Portfolio
                     14.3.9.4. SWOT Analysis 
                     14.3.9.5. Strategic Overview
            14.3.10. Cognizant Technology Solutions Corporation
                     14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.10.2. Financial Overview
                     14.3.10.3. Product Portfolio
                     14.3.10.4. SWOT Analysis 
                     14.3.10.5. Strategic Overview
            14.3.11. DSG, Inc.
                     14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.11.2. Financial Overview
                     14.3.11.3. Product Portfolio
                     14.3.11.4. SWOT Analysis 
                     14.3.11.5. Strategic Overview
            14.3.12. Forte Research Systems, Inc.
                     14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.12.2. Financial Overview
                     14.3.12.3. Product Portfolio
                     14.3.12.4. SWOT Analysis 
                     14.3.12.5. Strategic Overview
            14.3.13. Veeva Systems
                     14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.13.2. Financial Overview
                     14.3.13.3. Product Portfolio
                     14.3.13.4. SWOT Analysis 
                     14.3.13.5. Strategic Overview
            14.3.14. DATATRAK Int
                     14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.14.2. Financial Overview
                     14.3.14.3. Product Portfolio
                     14.3.14.4. SWOT Analysis 
                     14.3.14.5. Strategic Overview

List of Tables 

Table 01: Global CTMS Market Size (US$ Mn) Forecast, by Mode of Delivery, 2015–2025
Table 02: Global CTMS Market Size (US$ Mn) Forecast, by Component, 2015–2025
Table 03: Global CTMS Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 04: Global CTMS Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 05: Global CTMS Market (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Clinical Trial Management (CTMS) Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 07: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Mode of Delivery, 2015–2025
Table 08: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Component, 2015–2025
Table 09: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 10: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 11: Europe Clinical Trial Management (CTMS) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 12: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Mode of Delivery, 2015–2025
Table 13: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Component, 2015–2025
Table 14: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 15: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 16: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 17: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by Mode of Delivery, 2015–2025
Table 18: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by Component, 2015–2025
Table 19: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 20: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 21: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Mode of Delivery, 2015–2025
Table 22: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Component, 2015–2025
Table 23: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Type, 2015–2025
Table 24: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 25: Market Footprint Analysis, by Regio

List of Figures

Figure 1: Global Clinical Trial Management System Market Size ($ Million) and Distribution by Geography, 2016 and 2025
Figure 2: Global Clinical Trial Management System Market, by Component and Mode of Delivery
Figure 3: Global Clinical Trial Management System Market, by type and end-user
Figure 4: Market Share by Region, 2016
Figure 5: Global Clinical Trial Management System, Market Opportunity Map, by Mode of Delivery and Component
Figure 6: Global Clinical Trial Management System, Market Opportunity Map, by Type and End-user
Figure 7: Global Clinical Trial Management System (CTSM) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 8: Global CTMS Market Value Share, by Mode of Delivery, 2016 and 2025
Figure 9: Global CTMS Market Attractiveness, by Mode of Delivery, 2017–2025
Figure 10: Cloud-based Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 11: Web-based Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 12: On-premise Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 13: Global CTMS Market Value Share, by Component, 2016 and 2025
Figure 14: Global CTMS Market Attractiveness, by Component, 2017–2025
Figure 15: Software Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 16: Hardware Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 17: Services Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 18: Global CTMS Market Value Share, by Type, 2016 and 2025
Figure 19: Global CTMS Market Attractiveness, by Type, 2017–2025
Figure 20: Enterprise based Clinical Trial Management System
Figure 21: Site based Clinical Trial Management System
Figure 22: Global CTMS Market Value Share, by End-user, 2016 and 2025
Figure 23: Global CTMS Market Attractiveness, by End-user, 2017–2025
Figure 24: Pharmaceutical Industries Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 25: Contract Research Organizations Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 26: Health Care Providers Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 27: Global CTMS Market Value Share, by Region, 2016 and 2025
Figure 28: Global CTMS Market Attractiveness, by Region, 2017–2025
Figure 29: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 30: North America Clinical Trial Management System (CTMS) Market Value Share, by Country, 2016 and 2025
Figure 31: North America Clinical Trial Management System (CTMS) Market Attractiveness, by Mode of Delivery, 2017–2025
Figure 32: North America Clinical Trial Management System (CTMS) Market Value Share, by Component, 2016 and 2025
Figure 33: North America Clinical Trial Management System (CTMS) Attractiveness, by Component, 2017–2025
Figure 34: North America Clinical Trial Management System (CTMS) Market Value Share, by Type, 2016 and 2025
Figure 35: North America Clinical Trial Management System (CTMS) Attractiveness, by Type, 2017–2025
Figure 36: North America Clinical Trial Management System (CTMS) Value Share, by End-user, 2016 and 2025
Figure 37: North America Clinical Trial Management System (CTMS) Attractiveness, by End-user, 2017–2025
Figure 38: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 39: : Europe Clinical Trial Management System (CTMS) Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 40: Europe Clinical Trial Management System (CTMS) Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 41: Europe Clinical Trial Management System (CTMS) Market Value Share, by Mode of Delivery, 2016 and 2025
Figure 42: Europe Clinical Trial Management System (CTMS) Market Attractiveness, by Mode of Delivery, 2017–2025
Figure 43: Europe Clinical Trial Management System (CTMS) Market Value Share, by Component, 2016 and 2025
Figure 44: Europe Clinical Trial Management System (CTMS) Attractiveness, by Component, 2017–2025
Figure 45: Europe Clinical Trial Management System (CTMS) Market Value Share, by Type, 2016 and 2025
Figure 46: Europe Clinical Trial Management System (CTMS) Attractiveness, by Type, 2017–2025
Figure 47: Europe Clinical Trial Management System (CTMS) Value Share, by End-user, 2016 and 2025
Figure 48: Europe Clinical Trial Management System (CTMS) Attractiveness, by End-user, 2017–2025
Figure 49: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
Figure 50: : Asia Clinical Trial Management Systems (CTMS) Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 51: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 52: Asia Clinical Trial Management Systems (CTMS) Market Value Share, by Mode of Delivery, 2016 and 2025
Figure 53: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by Mode of Delivery, 2017–2025
Figure 54: Asia Clinical Trial Management Systems (CTMS) Market Value Share, by Component, 2016 and 2025
Figure 55: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by Component, 2017–2025
Figure 56: Asia Clinical Trial Management Systems (CTMS) Market Value Share, by Type, 2016 and 2025
Figure 57: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by Type, 2017–2025
Figure 58: Asia Clinical Trial Management Systems (CTMS) Market Value Share, by End-user, 2016 and 2025
Figure 59: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by End-user, 2017–2025
Figure 60: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 61: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Value Share, by Mode of Delivery, 2016 and 2025
Figure 62: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Attractiveness, by Mode of Delivery, 2017–2025
Figure 63: Rest of the World (RoW)Clinical Trial Management System (CTMS) Market Value Share, by Component, 2016 and 2025
Figure 64: Rest of the World (RoW)Clinical Trial Management System (CTMS) Attractiveness, by Component, 2017–2025
Figure 65: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Value Share, by Type, 2016 and 2025
Figure 66: Rest of the World (RoW) Clinical Trial Management System (CTMS) Attractiveness, by Type, 2017–2025
Figure 67: Rest of the World (RoW)Clinical Trial Management System (CTMS) Value Share, by End-user, 2016 and 2025
Figure 68: Rest of the World (RoW)Clinical Trial Management System (CTMS) Attractiveness, by End-user, 2017–2025
Figure 69: Global Clinical Trial Management System  Market Share Analysis, by Key Players (2016)
Figure 70: Oracle’s Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 71: Breakdown of Oracle’s Revenue, by Region, 2016
Figure 72: Breakdown of Oracle’s Revenue, by Business Segment, 2016
Figure 73: Oracle’s Research & Development Expenditure (US$ Mn) and Intensity (%), 2016 and 2015
Figure 74: Medidata Solutions, Inc Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 75: Medidata Solutions, Inc Revenue(US$ Mn), by Subscription Business Segment, 2016
Figure 76: Medidata Solutions, Inc Revenue (US$ Mn), by Professional Services Business Segment, 2016
Figure 77: Medidata Solutions, Inc R&D Expenditure (US$ Mn), 2015–2016
Figure 78: PAREXEL International Corporation Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 79: PAREXEL International Corporation Revenue (US$ Mn), by Business Segment, 2016
Figure 80: PAREXEL International Corporation Revenue (US$ Mn), by Geography, 2016
Figure 81: PAREXEL International Corporation Selling, General and Administrative Expenditure (US$ Mn), 2015–2016
Figure 82: International Business Machines Corporation Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 83: International Business Machines Corporation Revenue (US$ Mn), by Subscription Business Segment, 2016
Figure 84: International Business Machines Corporation S,G&A Expenditure (US$ Mn), 2016
Figure 85: International Business Machines Corporation R&D Expenditure (US$ Mn), 2015–2016
Figure 86: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 87: Gross Margin (Bn) and Y-o-Y Growth (%), 2014-2016
Figure 88: Operating Income (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 89: Assets (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 90: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 91: Gross Margin (Bn) and Y-o-Y Growth (%), 2014-2016
Figure 92: Net Income (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 93: R&D Expense (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 94: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 95: Gross Income (Bn) and Y-o-Y Growth (%), 2014-2016
Figure 96: R&D Expenses  (US$ Bn) and Y-o-Y Growth (%), 2015–2016
Figure 97: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 98: Gross Income (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 99: Revenue, by Business Segment, 2016
Figure 100: Revenue, by Geography, 2016
Figure 101: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 102: Gross Income (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 103: SG&A Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2016
Figure 104: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2016
Figure 105: DATATRAK Int Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 106: DATATRAK INT Gross Income (US$ Mn) & Y-o-Y Growth (%), 2014–2016
Figure 107: DATATRAK Int SG&A Expenditure (US$ Mn), 2016
Figure 108: DATATRAK Int Research & Development Expenditure (US$ Mn), 2016 and 2015

.